[HTML][HTML] The role of interleukins in colorectal cancer

J Li, L Huang, H Zhao, Y Yan, J Lu - International journal of …, 2020 - ncbi.nlm.nih.gov
Despite great progress has been made in treatment strategies, colorectal cancer (CRC)
remains the predominant life-threatening malignancy with the feature of high morbidity and …

Tumor-related interleukins: old validated targets for new anti-cancer drug development

S Setrerrahmane, H Xu - Molecular cancer, 2017 - Springer
In-depth knowledge of cancer molecular and cellular mechanisms have revealed a strong
regulation of cancer development and progression by the inflammation which orchestrates …

[HTML][HTML] Molecular aspects and future perspectives of cytokine-based anti-cancer immunotherapy

DS Chulpanova, KV Kitaeva, AR Green… - Frontiers in cell and …, 2020 - frontiersin.org
Cytokine-based immunotherapy is a promising field in the cancer treatment, since cytokines,
as proteins of the immune system, are able to modulate the host immune response toward …

[HTML][HTML] Role of hypoxia in inhibiting dendritic cells by VEGF signaling in tumor microenvironments: mechanism and application

Z Han, Y Dong, J Lu, F Yang, Y Zheng… - American Journal of …, 2021 - ncbi.nlm.nih.gov
The tumor microenvironment (TME) plays a central role in tumor initiation, development,
immune escape, and clinical treatment. Hypoxia, an important characteristic of the TME …

T-cell-based immunotherapy in colorectal cancer

M Feng, Z Zhao, M Yang, J Ji, D Zhu - Cancer letters, 2021 - Elsevier
Colorectal cancer (CRC) is the leading cause of cancer death worldwide. CRC therapeutic
strategies include surgical resection, chemotherapy, radiotherapy, and other approaches …

[HTML][HTML] The therapeutic potential of tackling tumor-induced dendritic cell dysfunction in colorectal cancer

B Subtil, A Cambi, DVF Tauriello… - Frontiers in …, 2021 - frontiersin.org
Colorectal cancer (CRC) is the third most diagnosed malignancy and the second leading
cause of cancer-related deaths worldwide. Locally advanced and metastatic disease exhibit …

[HTML][HTML] Perspectives on immunotherapy of metastatic colorectal cancer

Y Dai, W Zhao, L Yue, X Dai, D Rong, F Wu, J Gu… - Frontiers in …, 2021 - frontiersin.org
Colorectal cancer, especially liver metastasis, is still a challenge worldwide. Traditional
treatment such as surgery, chemotherapy and radiotherapy have been difficult to be further …

[HTML][HTML] Advances in human dendritic cell-based immunotherapy against gastrointestinal cancer

L Ni - Frontiers in immunology, 2022 - frontiersin.org
Dendritic cells (DCs), the strongest antigen-presenting cells, are a focus for orchestrating the
immune system in the fight against cancer. Basic scientific investigations elucidating the …

Combinatorial immunotherapies for metastatic colorectal cancer

E Janssen, B Subtil, F de la Jara Ortiz, HMW Verheul… - Cancers, 2020 - mdpi.com
Colorectal cancer (CRC) is one of the most frequent and deadly forms of cancer. About half
of patients are affected by metastasis, with the cancer spreading to eg, liver, lungs or the …

Immune dysfunctions and immunotherapy in colorectal cancer: the role of dendritic cells

S Gessani, F Belardelli - Cancers, 2019 - mdpi.com
Colorectal cancer (CRC), a multi-step malignancy showing increasing incidence in today's
societies, represents an important worldwide health issue. Exogenous factors, such as …